Glimpses
Marcolin Group names new
CEO for North America Essilor Gold Sponsor
of 2nd WCO
Marcolin Group has announced the appointment
of Davide Rettore as CEO North America for
Marcolin USA Eyewear Corp. Essilor is a proud Gold sponsor of the 2nd World
Congress of Optometry (WCO) in Hyderabad,
India. In line with Essilor’s mission of improving
lives by improving sight, the Congress will focus
on “accessible, quality vision and eye health."
“We all welcome back Davide to Marcolin Group,”
says Giovanni Zoppas, CEO of Marcolin Group.
“I know he will be a great value added to an
already strong team.”
Rettore’s solid experience and deep knowledge
of the industry will bring to the Group additional
expertise and value, the company said in a release.
In his role he will be responsible for the devel-
opment of the business in the USA and Canada.
“We are excited to welcome Davide to our US
Executive Team,” says Massimo Renon, Marcolin
Group’s worldwide commercial general manager.
“His experience and unique profile will comple-
ment and enhance Marcolin Group’s ability to
meet the needs of our customers.”
North America is a key market for Marcolin
Group, representing almost 45 per cent of
global sales, with a high potential to be further
explored both for ophthalmic eyewear and
sunglasses, leveraging on the company’s well-
known capabilities in terms of designing and
manufacturing quality.
42 Optical Prism November 2017
Essilor is committed to partnering with the
WCO to raise awareness on the importance of
vision and the key role of optometrists in provid-
ing vision care to patients and customers
around the world.
More than 1,200 eye care professionals are
expected to attend the Congress which will this
year focus on accessible, quality vision and
eye health.
The theme relates to the WHO “Universal Eye
Health: A global Action plan 2014-2019” targeting
a 25 per cent reduction of avoidable vision
impairment by 2019. Lectures and seminars will
be presented by leading experts from across the
globe, featuring cutting edge research and clinical
practice. The Congress also serves to define the
agenda of accessible vision care.